European Union (EU) companies operating in India want New Delhi to streamline or remove non-tariff barriers such as Quality Control Orders (QCOs), complex Customs procedures; simplify labelling, testing, and import procedures; and facilitate cross-border digital transactions without data localisation constraints. These are results of a Business Sentiment Survey, 2025 conducted by the Federation of European Business in India (FEBI) ahead of resumption of negotiations for a free trade agreement (FTA) between both the sides scheduled to be concluded by year-end.
The varieties will take at least 4 to 5 years to reach farmers after they complete the usual cycle of breeder, foundation and certified seeds.
Dining today isn't just about food -- it's about the experience and the story.
JV to export e-carts, aim for 10% global market share, $1 bn turnover and innovation in driverless tech.
There is a need to incentivise R&D investments, offer corporate tax concessions and establish an effective intellectual property rights regime in order to push the growth of domestic pharmaceutical industry, as per the industry bodies. Outlining the sector's wish list for the upcoming Union Budget, Organisation of Pharmaceutical Producers of India (OPPI) Director General Anil Matai urged the government to explore methods to incentivise R&D investments, such as deductions on R&D expenses, research-linked incentives for MNCs, and corporate tax concessions.
'The satisfaction of making content only comes when it reaches theatres as you are directly connecting to the masses.'
Communications between the USTR and the world's most powerful pharmaceutical and trade lobbying groups reveal that many raised concerns about India's push to exempt Covid vaccines from intellectual property.
'Make-in-India played a key role in India's effective action against terrorism during Operation Sindoor.'
'What the US appears to be doing is to force India to be "the buyer of last resort", on whom their products can be dumped, 1.4 billion people have to eat something, so why not eat American corn?' 'What is exercising the Trump lot is the fact that most of the farms are in solidly Republican Midwestern states: Illinois, Indiana, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, Wisconsin,' points out Rajeev Srinivasan.
American President Donald Trump has announced imposing reciprocal tariffs on its major trading partners including China that levy higher import duties on goods shipped from the United States. He has already announced a 25 per cent duty on steel and aluminium imports, which will come into effect from March 12.
'As negotiations continue, the path forward demands not only diplomatic skill, but also vigilance against legal asymmetries embedded in America's trade playbook.'
The Indian Navy, which was earlier looking towards the US for design expertise, technical know-how and operational practices, is now considering the advantages of working with the Royal Navy.
All that you must know about the pros and cons of gift deeds, tax implications, essentials, documents required, conditions, etc...
India has a huge trade surplus with US - over $20 billion a year in the past five years.
Data contradict Swiss drug major's claim that India does not respect IPR.
The challenge for India will be to ensure the law does not get out of step with the demands of a country that needs foreign investment and new technologies.
Leading FMCG maker HUL said that it has received a demand notice of Rs 962.75 crore from the Income Tax Department and will go in for an appeal against the order. The notice relates to non-deduction of TDS on payment of Rs 3,045 crore to GlaxoSmithKline Consumer Healthcare (GSKCH) for the acquisition of Intellectual Property Rights of the Health Foods Drinks (HFD) business consisting of brands as Horlicks, Boost, Maltova, and Viva, according to a recent exchange filing.
To date, no comprehensive analysis has been done on the impact of intellectual property on India's economy, according to US Consul General Jennifer A McIntyre.
Twelve countries - India, Pakistan, China, Russia, Algeria, Argentina, Canada, Chile, Indonesia, Israel, Thailand and Venezuela - are on the Priority Watch List.
The US will help India set up a body similar to the Food and Drug Administration, to certify clinical trials for automatic acceptance in the US market
'The law under the guise of security represents a grave and unnecessary expansion of State power at the cost of fundamental rights,' asserts Aakar Patel.
The migration of domestically developed intellectual property to foreign corporations within India reflects an anomaly in the demand pattern of the country's job market, points out Kanika Datta.
India and the US on Sunday agreed to enhance their engagement on intellectual property rights, a vexed issue between the two countries.
Data exclusivity provides protection to the technical data generated by innovator companies to prove the merit of usefulness of their products.
Prime Minister Narendra Modi urged CEOs of US majors to take advantage of India's growth story as the country is making all efforts to become the third largest economy of the world in his third term. India is currently the fifth largest economy of the world after the US, China, Germany and Japan with a GDP of around $3.9 trillion. India has been the fastest growing large economies of the world with GDP growth rate of over 7 per cent for the last three consecutive years.
Numeros Motors is also planning to come up with a passenger vehicle four-wheeler or a three-wheeler by 2027.
'We don't have to compete with Maharashtra or Gujarat. We have to now start thinking about how we compete with the United States or China.'
The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.The US pharma industry has expressed concern over deteriorating intellectual property environment in India, alleging that patent rights in the country are unreasonably denied.
'Son believes India has a significant opportunity in chip design, especially in creating IP that will be uniquely Indian.'
Developed countries, especially the United States, are of the view that these issues have been settled in Mexico's Cancun.
A task force set up by the Ministry of Electronics and Information Technology (Meity) for transforming India into an "electronic and semiconductor products" nation is on the verge of finalising its report, which is likely to recommend an allocation of Rs 44,000 crore between 2024 and 2030 to support homegrown companies in their quest to develop products and build global brands. The task force's recommendations include significant incentives: Rs 15,000 crore dedicated to electronic products (systems), Rs 11,000 crore for semiconductor products, and Rs 18,000 crore for various other incentives such as talent development, common infrastructure, logistics, and technology & IP (intellectual property) acquisition, a member of the panel revealed.
'While criticising India's high tariffs, Mr Trump stated he would impose reciprocal taxes on Indian products if re-elected.' 'However, since India's tariffs follow WTO rules, Mr Trump's actions would violate these rules,' Ajay Srivastava points out.
'If you align your ambition with India's rise, the peak of your careers will unfold alongside the peak of India's power.'
The data for 2009 reveals that Indian firms and scientists filed one-tenth of patent applications filed by their Chinese counterparts during the same period.
Global cryptocurrency giant Binance has asserted that it never owned or controlled WazirX before or after the embattled Indian exchange was hacked in July that led to a security breach of more than $230 million. Binance added that there was no legal basis for the firm to be liable for claims made against the embattled crypto exchange. It refuted WazirX's claims that the global exchange owns the company, adding that it does not operate the platform.
'But I don't think the government is in a great hurry to sign the BTA.'
Negotiations for a trade deal between India and the UK have run into fresh controversy, after the proposals under a leaked chapter of the deal on intellectual property (IP) are believed to put access to affordable, lifesaving generic medicines from India at risk. According to the draft IP chapter put out by an international trade portal bilaterals.org, the UK is seeking continuous extension of patent period and rights through small tweaks in the drug, known as evergreening. This may prevent patents from expiring, impacting cheaper drug availability and its production by Indian generic drug manufacturers.
Asserting that India was on the 'threshold of a new era' in the textiles sector, Prime Minister Manmohan Singh on Friday cautioned that the country must take steps to protect the intellectual property of its weavers, artisans and designers.
